Savana, a NYC-based healthtech startup accelerating health science with big data, raised $15m in B Series funding.
The round was led by Cathay Innovation with participation from Seaya Ventures, as well as new investors, such as MACSF, the French mutual insurer for health professionals.
The company intends to use the funds to support its international expansion and operations in the US.
Founded in 2014 in Spain and led by CEO Jorge Tello and CMO Dr Ignacio Hernandez Medrano, Savana develops artificial intelligence (AI) solutions that provide doctors and pharmacists with insights into patients’ healthcare by surfacing critical information within the free text of clinical notes. Its SaaS platform has over 400 million Electronic Medical Records processed in English, Spanish, German and French.
The company’s technologies and services have been adopted by health systems across Western Europe, the United States and Canada and Savana already works with the top 20 pharmaceutical companies in the world and more than a hundred healthcare facilities.
The team is currently composed of 100+ professionals and over the next year the team at headquarters in New York City is expected to grow by between 20 to 30 people.